Gastrointestinal Bleeding Treatment Devices Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

What combination of drivers is leading to accelerated growth in the gastrointestinal bleeding treatment devices market?
The escalation of upper gastrointestinal bleeding incidents is anticipated to foster the expansion of the gastrointestinal bleeding treatment devices market through the projection period. Upper gastrointestinal bleeding transpires in the esophagus, stomach, or top portion of the small intestine, with potential causes including peptic ulcers, esophagitis, enteritis, gastritis, cancer, among others. For example, data from the National Institute for Health and Care Excellence indicates that in the UK, acute upper gastrointestinal bleeding incidences range from 84-172 per 100,000 of the population annually. Adding to it, research released in the National Library of Medicine - National Institutes of Health in 2023 shows that the mortality rates in-hospital for upper GI bleeds are about 10%. This percentage continues to be constant up to a month after hospitalization due to GI bleeding. Over an extended duration, about three years post-admission, the mortality rates for all causes escalates to nearly 37%.

Get Your Gastrointestinal Bleeding Treatment Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

What is the projected compound annual growth rate (CAGR) of the gastrointestinal bleeding treatment devices market from 2025 to 2034, and what factors influence it?
In recent times, the market size for devices used in treating gastrointestinal bleeding has witnessed significant growth. It's projected to increase from $0.87 billion in 2024 to about $0.93 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.1%. The substantial growth during the historic period may be tied to factors such as an ageing populace, lifestyle influences, improvements in healthcare infrastructure, prevalence of gastrointestinal maladies, and advancements in endoscopy techniques.

It is anticipated that the market for devices treating gastrointestinal bleeding will witness considerable expansion in the coming years. By 2029, it is projected to reach $1.3 billion, growing at a compound annual growth rate (CAGR) of 8.9%. This increase over the forecast period can be associated with factors such as focused patient care, regulatory amendments, the rise of telemedicine and remote consultations, surge in gastrointestinal ailments, and healthcare investment. Additionally, significant trends during the prediction period include non-invasive diagnostic technologies, precision medicine, remote monitoring and telehealth, as well as the implementation of artificial intelligence and machine learning.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

How are the latest trends influencing the growth of the gastrointestinal bleeding treatment devices market?
Prominent firms in the gastrointestinal bleeding treatment devices market are channeling their efforts towards the development of innovative solutions like the EVIS X1 endoscopy system. The aim is to increase diagnostic accuracy, achieve improved results for patients, and make clinical workflows more efficient. EVIS X1 is a state-of-the-art endoscopic imaging system, tailored to enhance diagnostic and therapeutic techniques in several medical fields, encompassing gastroenterology, pulmonology, and urology. In November 2023, Olympus Corporation, a medical and surgical technologies firm based in Japan, unveiled its sophisticated EVIS X1 endoscopy system. This next-generation evolution in endoscopic imaging technology is engineered to reinforce diagnostic capabilities, boost procedural productivity, and promote better clinical outcomes. The newly evolved EVIS X1 incorporates advanced imaging techniques, user-friendly navigation, and the assistance of artificial intelligence (AI). These improvements are customized to meet the demands of a variety of medical applications, notably relating to gastroenterology and pulmonology.

What are the major segments of the gastrointestinal bleeding treatment devices market and their role in driving growth?
The gastrointestinal bleeding treatment devices market covered in this report is segmented -

1) By Product: Endoscopic Thermal Devices, Other Products
2) By GI Tract Division: Upper GI Tract, Lower GI Tract
3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

Subsegments:
1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices
2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5307

Which regions are key players in the growth of the gastrointestinal bleeding treatment devices market?
North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the key firms paving the way for growth in the gastrointestinal bleeding treatment devices market?
Major companies operating in the gastrointestinal bleeding treatment devices market include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc., Medtronic, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Medline Industries Inc. Smiths Medical, Terumo Corporation, Nipro Corporation, ConvaTec Group PLC, Coloplast A/S, Hollister Incorporated, Wellspect HealthCare, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

What Is Covered In The Gastrointestinal Bleeding Treatment Devices Global Market Report?

•Market Size Forecast: Examine the gastrointestinal bleeding treatment devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the gastrointestinal bleeding treatment devices market for a structured understanding.
•Key Players Overview: Analyze major players in the gastrointestinal bleeding treatment devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the gastrointestinal bleeding treatment devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the gastrointestinal bleeding treatment devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the gastrointestinal bleeding treatment devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the gastrointestinal bleeding treatment devices market.
•Competitive Landscape: Review strategic developments in the gastrointestinal bleeding treatment devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.